Expanded program of immunization in the Maghreb. Case study of Tunisia.Systematic review of the literature

##plugins.themes.academic_pro.article.main##

Meriem Kacem
Wafa Dhouib
Cyrine Bennasrallah
Imen Zemni
Hela Abroug
Manel Ben Fredj
Asma Sriha Belguith

Abstract

Background: Vaccination is the most cost-effective intervention for primary prevention. The Maghreb countries had joined the The Expanded Programme on Immunization (EPI). Tunisia had also introduced the vaccine against hepatitis B and Haemophilus influenzae type B (Hib).
Objective: To describ, through a systematic review, the specific documentation on the EPI in Tunisia.
Method: Target publications were collected using Medline database and Google Scholar from published articles from January 01 1998 to December 12 2017. The synthesis of the data was done according to four axes: "input", "process", "output" and "outcome".
Results: 17 articles were analyzed, with an average of 4 publications every 5 years. The author's specialty was community and preventive medicine in 56% of cases. Six articles focused on the "input" vaccination program, five related to the immunization process and the other five articles examined output and outcomes.
Conclusion: Tunisian publications concerning vaccination were rare, their efficiency and impact on the change of national vaccination strategy was crucial. Research coordination between Maghreb countries is highly recommended to meet the growing information needs.

Keywords:

Vaccination - Immunization - Immunization Programs - Review - Africa, Northern - Tunisia

##plugins.themes.academic_pro.article.details##

References

  1. Bärnighausen T, Bloom DE, Cafiero ET, O'Brien JC. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18 Suppl 5:70‑6.
  2. WW H. The case for vaccines. - PubMed - NCBI. [cité 17 juin 2018]. Disponible sur: http://sci-hub.tw/https://www.ncbi.nlm.nih.gov/pubmed/23444585
  3. Cohen R. The need for prudent use of antibiotics and routine use of vaccines. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2009;15 Suppl 3:21‑3.
  4. Lahariya, C. A brief history of vaccines & vaccination in India. The Indian Journal of Medical Research, 2014; 139, 491-511.
  5. Dellepiane N, Wood D. Twenty-five years of the WHO vaccines prequalification programme (1987-2012): Lessons learned and future perspectives. Vaccine. 2015;33:52-61.
  6. Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2014;369:20130433.
  7. Hotez PJ. “Vaccine Diplomacy”: Historical Perspectives and Future Directions. PLoS Negl Trop Dis. 2014;8:e2808.
  8. Robertson CA. The science of vaccination: establishing safety and efficacy. S D Med J S D State Med Assoc. 2013;Spec no:38-45.
  9. Lloyd J, Lydon P, Ouhichi R, Zaffran M. Reducing the loss of vaccines from accidental freezing in the cold chain: The experience of continuous temperature monitoring in Tunisia. Vaccine. 2015;33:902-7.
  10. Kamara L, Lydon P, Bilous J, Vandelaer J, Eggers R, Gacic-Dobo M, et al. Global Immunization Vision and Strategy (GIVS): a mid-term analysis of progress in 50 countries. Health Policy Plan. 2013;28:11-9.
  11. Aounallah-Skhiri H, Lazaar-Ben Gobrane H, Hsairi M, Achour N, Zouari B, Nacef T. Medical demography in Tunisia: current situation and perspectives. Tunis Med. 2012;90:166-71.
  12. Soltani MS, Bchir A, Amri F, Gueddiche N, Sfar T, Sahloul S, et al. Epidémiologie de la méningite à Haemophilus influenzae en Tunisie. East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. 2005;11:14-27.
  13. Zouari A, Smaoui H, Njamkepo E, Mnif K, Ben Jaballah N, Bousnina S, et al. [The re-emergence of pertussis in Tunisia]. Med Mal Infect. 2011;41:97-101.
  14. Ben Haj Khalifa A, Berriri S, Kheder M. [Séroprévalence de la rubéole parmi le jeune personnel féminin hospitalier à l'hôpital universitaire Tahar Sfar de Mahdia, Tunisie.. Med Mal Infect. 2011;41:493-4.
  15. Chaabouni M, Messadi F, Fki L, M Z, Hammami A, Karray H. Séroprévalence de la rubéole chez la femme en âge de procréer deux ans après l'introduction de la vaccination en Tunisie. Pathol Biol (Paris). 2012;60:170-3.
  16. Soltani M, Bouanene I, Trabelsi A, Harbi A, Hachicha M, Amri F, et al. Épidémiologie des gastroentérites à rotavirus chez les enfants âgés de moins de cinq ans en Tunisie - Résultats de la surveillance sentinelle hospitalière 2009 à 2011. 2012. RESP; 6 : 473-480
  17. Soltani MS, Ben Salah A, Bouanene I, Trabelsi A, Sfar MT, Harbi A, et al. Epidemiology and medical cost of hospitalization due to rotavirus gastroenteritis among children under 5 years of age in the central-east of Tunisia. East Mediterr Health J. 2015;21:584-90.
  18. Guettiti H, Ennaifer E, Attia L, Chelly D, Alaya NB, Aissa RB, et al. Pre-vaccination prevalence and genotype distribution of human papillomavirus infection among women from urban Tunis: a cross-sectional study. Asian Pac J Cancer Prev APJCP. 2014;15:9361-5.
  19. Soltani MS, Belghith Z, Gacem H, Bchir A. Valeur de l'analyse des données de vaccination au niveau du district. East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. 1999;5(3):565-71.
  20. J Battersby, P Le Feuvre, L Hamzaoui,. A Method for Improving Vaccination Coverage in Rural Tunisia . Trop Doc. 2001 : 100-102
  21. Saadallah N, Jaoua N, Ben Hamida A, Najjar T, Zouari B. Vaccination against viral hepatitis B for public health personnel: the case of the National Fund of Social Security. TUN Med. 2001;79:676-80.
  22. Bouanene I, Trimech F, Ben Salah A, Ben Salem Kamel K, El Mhamdi S. Audit sur la qualité de la vaccination en milieu scolaire dans la région de Monastir (Tunisie). East Mediterr Health J. 2017;23:383-7.
  23. Langar H, Triki H, Gouider E, Bahri O, Djebbi A, Sadraoui A, et al. [Blood-transmitted viral infections among haemophiliacs in Tunisia]. Transfus Clin Biol J Soc Francaise Transfus Sang. 2005;12:301-5.
  24. Elloumi-Zghal H, Barbouche MR, Chemli J, Béjaoui M, Harbi A, Snoussi N, et al. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guérin infection. J Infect Dis. 2002;185:1468-75.
  25. Haddad-Boubaker S, Ould-Mohamed-Abdallah MV, Ben-Yahia A, Triki H. [Genetic recombination in vaccine poliovirus: comparative study in strains excreted in course of vaccination by oral poliovirus vaccine and circulating strains]. Pathol Biol (Paris). 2010;58:420-5.
  26. Gargouri I, Jmal-LHammami K, Sobaszek A, Masmoudi H, Karray H, Hammami A, et al. La vaccination anti-hépatite B aux établissements publics de santé de Sfax (Tunisie). Archives des Maladies Professionnelles et de l'Environnement. 2011 ; 1 : 36-43.
  27. Chaouch H, Hachfi W, Letaief A. Decreasing the hepatitis B burden in Tunisia need more attention to adults for vaccination. Epidemiol Infect. 2017;145:1510-1.
  28. Okoli C, Schabram K. A Guide to Conducting a Systematic Literature Review of Information Systems Research. SSRN Electron J. 2010 [cité 18 juill 2018]; Disponible sur: http://www.ssrn.com/abstract=1954824.
  29. Richard Mihigo, Nadia Abdel-Aziz Teleb Badr, Helena O'Malley et Irtaza, Chaudhri. TENIR LA PROMESSE : ASSURER LA VACCINATION POUR TOUS EN AFRIQUE. 2016.
  30. Gargouri S, Fki-Berrajah L, Messedi E, Chaari A, Bouaziz M, Hammami A, et al. Survenue d'une épidémie de rubéole à Sfax en Tunisie en 2011-2012 caractérisée par un nombre élevé de formes sévères. 2014;18:3.
  31. Groom H, Hopkins DP, Pabst LJ, Murphy Morgan J, Patel M, Calonge N, et al. Immunization Information Systems to Increase Vaccination Rates: A Community Guide Systematic Review. J Public Health Manag Pract. 2015;21:227-48
  32. Bulletin Retro Info PNV _ 2014. [cité 23 juill 2018]. Disponible sur: http://www.isst.nat.tn/uploads/FCK_files/Bulletin%20Retro_Info%20PNV%20_%202014%20final%20(1)%20(1)(1).pdf
  33. Kourime M, Akpalu ENK, H. Ouair, Jeddane L, Benhsaien I, Ailal F, et al. Bécégites de l'enfant : diagnostic, classification et exploration. Arch Pédiatrie. 2016;23:754-9.
  34. May_2014_Polio_final_FR.pdf . [cité 26 juill 2018]. Disponible sur: http://www.who.int/vaccine_safety/initiative/tools/May_2014_Polio_final_FR.pdf